Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Africa: dependable supply of HIV testing reagents needed for crucial early stage TB/HIV testing

This article was originally published in Clinica

Executive Summary

Lack of a regular supply of HIV testing reagents is hindering the progress of an integrated TB/HIV testing programme in Malawi. The problem is highlighted in a review of a 2003-2005 HIV testing plan recently published in The International Journal of Public Health 2007 (Bulletin of the World Health Organization). Despite this setback, the initiative's effort to scale up HIV testing for TB and HIV-positive TB patients (one among several objectives) was successful, achieving an increase in HIV tests from 15% in 2003 to 47% in 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel